3.0.0 2244 2023-01-11T13:35:53Z 2023-01-11T13:35:53Z House HR 2017-04-28 115 [Congressional Record Volume 163, Number 73 (Friday, April 28, 2017)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. LANCE:H.R. 2244.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3, of the United StatesConstitution, which states that the Congress shall have powerto regulate Commerce with foreign nations, and among theseveral states, and with the Indian Tribes.Article I, Section 8, Clause 18, which states that theCongress shall have the power to make all laws which shall benecessary and proper for carrying into execution theforegoing powers, and all other powers vested by theConstitution of the United States.[Page H2973]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2017-05-05T15:26:38Z Referred to 2017-04-28T13:03:35Z 2017-05-05 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2017-04-28 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2017-04-28 Introduced in House IntroReferral Intro-H 9 Library of Congress 2017-04-28 Introduced in House IntroReferral 1000 9 Library of Congress L000567 Rep. Lance, Leonard [R-NJ-7] Leonard Lance R NJ 7 N D000197 Rep. DeGette, Diana [D-CO-1] DIANA DEGETTE D CO 1 2017-04-28 True C001067 Rep. Clarke, Yvette D. [D-NY-9] Yvette Clarke D NY D. 9 2017-05-22 False E000215 Rep. Eshoo, Anna G. [D-CA-18] ANNA ESHOO D CA G. 18 2017-05-22 False Health Drug safety, medical device, and laboratory regulation Medical research Mental health User charges and fees Health

00 2017-04-28 Introduced in House 2017-07-18T18:45:48Z Patient Experience in Research Act of 2017

This bill requires the Food and Drug Administration to carry out a pilot project under which sponsors of new drugs or biological products agree to evaluate: (1) the distress experienced by patients in clinical trials for medications intended to treat a serious condition, and (2) the effects of providing support to distressed patients on the outcome of a clinical trial. The user fee is waived for new drug applications that include data from such an evaluation.]]>

Display Title Official Title as Introduced Introduced in House IH Short Titles as Introduced Introduced in House 2017-04-28T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr2244ih/xml/BILLS-115hr2244ih.xml 2017-05-05 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.